Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 8,530.00
+30.00 (0.35%)
At close: Aug 11, 2026
Biodyne Market Cap
Biodyne has a market cap or net worth of 251.44 billion as of August 12, 2026. Its market cap has decreased by -46.80% in one year.
Market Cap
251.44B
Enterprise Value
236.22B
Revenue
6.98B
Ranking
n/a
PE Ratio
175.10
Stock Price
8,530.00
ChartMarket Cap Chart
Since March 17, 2021, Biodyne's market cap has decreased from 252.12B to 251.44B, a decrease of -0.27%. That is a compound annual growth rate of -0.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 251.44B | -37.42% |
| Dec 30, 2025 | 401.82B | -16.15% |
| Dec 30, 2024 | 479.20B | 19.24% |
| Dec 28, 2023 | 401.88B | 185.76% |
| Dec 29, 2022 | 140.63B | -31.74% |
| Dec 30, 2021 | 206.02B | -18.28% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Livsmed | 1.16T |
| Curiox Biosystems | 708.77B |
| M.I.TECH Co.,Ltd | 164.42B |
| BIOBIJOU | 161.73B |
| Synergy Innovation | 147.58B |
| RecensMedical | 117.07B |
| Celemics | 114.50B |
| Corentec | 56.71B |